Skip to content
DataLookout
Menu

NCT05911243

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

StatusTerminated
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 13 versions: 12 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 3, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints revised (4)
    • Primary endpoints revised (5)
    • Site details revised
  2. Stopped Trial status: Recruiting to Terminated Sponsor's reason: Study closed per SRC Low Accrual Policy.v12 Show 4 more changesShow less
    • Enrollment target: estimated 66 to confirmed 3
    • Primary completion date changed from estimate of Sep 1, 2026 to Jul 9, 2025
    • Study completion date changed from estimate of Dec 31, 2026 to Jul 9, 2025
    • Site details revised
  3. Notable Primary completion date: Feb 1, 2026 to Sep 1, 2026
    • Study completion date: Apr 30, 2026 to Dec 31, 2026
    v11
  4. Notable Eligibility criteria shortened, about 6 wordsv10
  5. Minor Primary completion date: Nov 30, 2025 to Feb 1, 2026
    • Study completion date: Mar 1, 2026 to Apr 30, 2026
    v9
Show 6 earlier versionsHide 6 earlier versions
  1. Minor Start date changed from estimate of Aug 11, 2024 to Jul 22, 2024v8
  2. Notable Start date: Jul 10, 2024 to Aug 11, 2024v7
  3. Notable Start date: Jun 8, 2024 to Jul 10, 2024v6
  4. Notable Trial status: Not Yet Recruiting to Recruitingv5 Show 4 more changesShow less
    • Primary completion date: Nov 30, 2024 to Nov 30, 2025
    • Start date: May 1, 2024 to Jun 8, 2024
    • Study completion date: Jan 31, 2025 to Mar 1, 2026
    • Site details revised
  5. Notable Start date: Feb 1, 2024 to May 1, 2024v4
  6. Notable Start date: Nov 1, 2023 to Feb 1, 2024v3
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Accrual (Feasibility)
Timeframe: Up to 2 years, during study accrual
Retention (Feasibility)
Timeframe: Up to 8 weeks
Intervention Adherence (Feasibility)
Timeframe: Up to 8 weeks
Intervention Fidelity (Feasibility)
Timeframe: Up to 8 weeks
Acceptability (Feasibility)
Timeframe: Up to 16 weeks

Secondary (2)

Change in Appetite
Change in Body Weight (kg)

Arms and interventions

Arm I (acupressure therapy)Experimental

Patients undergo auricular acupressure in addition to their usual care on study. Patients also undergo collection of blood samples on study.

Arm II (usual care)Active comparator

Patients receive usual care on study. Patients also undergo collection of blood samples on study.

Procedures: Acupressure Therapy, Biospecimen Collection

Other: Best Practice, Questionnaire Administration

Sites

1 site in 1 country

  • Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington, United States